Cis-diamminedichloroplatinum (NSC-119875): a phase I study.
D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007263:Infusions, Parenteral; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009336:Necrosis / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced
D002945:Cisplatin